| Product Name | Latanoprost - Impurity G |
| Product Code | DA-L018-w |
| Chemical name | Methyl (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate |
| Synonyms | Latanoprost Methyl Ester; Methyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R)-3-hydroxy-5-phenylpentyl)cyclopentyl)hept-5-enoate; Methyl (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate; |
| Impurity | NA |
| CAS Number | 913258-31-8 |
| Alternate CAS # | NA |
| Molecular form | C24H36O5 |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 404.55 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | impurities,metabolites,pharmaceutical standards,Fine Chemicals |
| Boiling Point | NA |
| Applications | Latanoprost Methyl Ester is an impurity of trans-Latanoprost, which is a Prostaglandin analog; prodrug of active acid metabolite. It is a synthetic derivative of the natural prostaglandin PGF2α, used as an anti-glaucoma agent that is effective in various types of glaucoma and ocular hypertension. Latanoprost USP Related Compound A._x000B__x000B_Lantanoprost Methyl Ester can be used for combination therapy for glaucoma. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
